Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07163221Not ApplicableRecruiting

At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]

Role: lead

NCT06189066Not ApplicableCompleted

Long COVID Ultrasound Trial

Role: lead

NCT04854798Not ApplicableCompleted

UNITE Study (UMN-SW) for COVID-19

Role: collaborator

NCT05417854Not ApplicableCompleted

Ultrasound Treatment for Rheumatoid Arthritis Study [ULTRA Study]

Role: lead

NCT04803409Not ApplicableUnknown

UNITE Study (UCSD-SW) for COVID-19

Role: collaborator

All 5 trials loaded